
FATE THERAPEUTICS INC
FATE · NASDAQ
Updated at 2026-10-14 09:06:44
$2.00-6.1%
- Today's High
- $2.13
- Today’s Low
- $1.98
...
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $2.13
- Previous Close
- $2.13
- Volume
- 616.84K
- Market Cap
- $255.21M
- P/E Ratio
- --
- EPS
- $-1.05
Previous Day Range
$2.10$2.18
52-Week Range
$0.95$3.23
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, UNITED STATES, 92131
- Country
- US
- Listing Date
- 2013-10-01
- Fiscal Year End
- December
- Shares Outstanding
- 116.56M
- CIK
- 0001434316
- Website
- fatetherapeutics.com
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders globally. The company is headquartered in San Diego, California.
Financial Metrics
--
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.